Pharmaceutical

6 burning questions about how the FDA will handle confl...

The FDA's drug approval process the “should stay as untouched by threats of liti...

STAT+: ‘It was my call’: Stanford president defends dec...

Stanford president Marc Tessier-Lavigne took responsibility for the decision not...

Where is PhRMA in the mifepristone debate?

PhRMA hasn’t put out a press release about a Texas judge suspending approval for...

Next abortion battles may be among states with clashing...

“If red states pass laws saying, ‘We can go after people for X, Y and Z,’ and bl...

STAT+: Pharmalittle: Abortion pill ruling could threate...

A federal judge's ruling to revoke longstanding FDA approval of the abortion pil...

STAT+: 5 to watch: Tech startups trying to solve health...

Staffing — and in particular, hiring nurses — is still a top concern for hospita...

Here’s a new data point for cancer patients to consider...

“As an oncologist, patients rely on us to convey to them the relative risks and ...

STAT+: UnitedHealth’s physician buying spree continues ...

UnitedHealth Group quietly acquired Crystal Run Healthcare, a physician group in...

Opinion: Why genetic testing should always be offered t...

These tests save families valuable time, helping them get to a diagnosis faster.

STAT+: Competing abortion pill rulings sow broad alarm,...

Competing rulings on the abortion pill from judges in Texas and Washington on th...

STAT+: FDA warns some Philips respirators may not deliv...

Some Philips respirators were incorrectly programmed with the wrong serial numbe...

Aviceda, QUB to develop next-generation glyco-immune th...

Aviceda’s HALOS is used to modulate the innate immune system to develop next-gen...

Malaysia approves additional indication for Astrazeneca...

Evusheld is intended to treat adult and adolescent Covid-19 patients aged 12 yea...

India’s Cipla signs licence deal with Novartis for diab...

Cipla will be responsible for the manufacturing and marketing of Galvus and its ...

Australia lists new medicines for GVHD and chronic rhin...

Jakavi is expected to benefit 225 patients with acute or chronic graft versus ho...

mRNA vaccine for cancer along with Keytruda obtains PRI...

The PRIME regulatory mechanism provides support for the development of medicines...